HIGHLIGHTS
- who: Morten Orebo Holmstru00f6m et al. from the National Center for Cancer Immune Therapy, Department of Oncology, Herlev University Hospital, Copenhagen N, Denmark have published the research: Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms, in the Journal: (JOURNAL)
- what: The authors provide a short overview of MPN and the current treatment modalities. In this model, chronic inflammation is hypothesized to induce the initial stem_cell hit by inducing genomic instability and mutations, giving rise to MPN .
SUMMARY
In the setting of hematological malignancies, this therapy in the form of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.